[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100485443":3},{"organization":4,"outcomesModule":7,"designInfo":18,"detailedDescription":17,"studyPopulation":20,"armGroups":17,"interventions":17,"overallOfficials":17,"centralContacts":17,"locations":21,"responsibleParty":45,"collaborators":17,"id":49,"slug":17,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":17,"enrollmentInfo":58,"targetDuration":61,"studyType":62,"phases":17,"briefSummary":63,"conditions":64,"keywords":17,"overallStatus":24,"whyStopped":17,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Azienda Ospedaliero-Universitaria di Modena","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":17},[9],{"measure":10,"description":11,"timeFrame":12},"Characterization of pituitary patients","The primary aim of the study is to characterize subjects with pituitary disease by collecting anamnestic, clinical, biohumoral, radiological data, and data related to the treatment approach, in terms of surgery, medical therapies and\u002For hormone replacement therapies.","10 years",[14],{"measure":15,"description":16,"timeFrame":12},"Management of pituitary patients","The second aim is to integrate these data with current knowledge, in order to improve the clinical-diagnostic-therapeutic management of patients suffering from pituitary diseases, as well as to identify risk factors for the development of the disease.",null,{"allocation":17,"interventionModel":17,"interventionModelDescription":17,"primaryPurpose":17,"observationalModel":19,"timePerspective":6,"maskingInfo":17},"COHORT","Patients affected by pituitary disorders who attended Unit of Endocrinology of Azienza Ospedaliero-Universitaria di Modena",[22],{"facility":23,"status":24,"city":25,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Unit of Endocrinology of Azienza Ospedaliero-Universitaria di Modena","RECRUITING","Modena","41126","Italy","IT",{"type":30,"coordinates":31},"Point",[32,33],10.92539,44.64783,{"lat":33,"lon":32},[36,41],{"name":37,"role":38,"phone":39,"phoneExt":17,"email":40},"Vincenzo Rochira, Professor","CONTACT","+390593962453","vincenzo.rochira@unimore.it",{"name":42,"role":38,"phone":43,"phoneExt":17,"email":44},"Chiara Diazzi, PhD","+390593961816","chiaradiazzi@gmail.com",{"type":46,"investigatorFullName":47,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":17,"oldOrganization":17},"PRINCIPAL_INVESTIGATOR","Vincenzo Rochira","MD, PhD - Associate Professor of Endocrinology","100485443",false,"NCT05601141","Clinics and Epidemiology of Pituitary Diseases in Modena Area Population","Pituitary Diseases in Modena Population: Clinical and Epidemiological Data Register of Pituitary Patients Attending the Unit of Endocrinology of Azienda Ospedaliero-Universitaria of Modena (DataPit)","DataPit","Inclusion Criteria:\n\n* subjects affected by pituitary disorders who attended Unit of Endocrinology of Azienza Ospedaliero-Universitaria di Modena\n\nExclusion Criteria:\n\n* subjects under 18 years old","ALL","18 Years",{"count":59,"type":60},1500,"ESTIMATED","10 Years","OBSERVATIONAL","This is an observational, longitudinal, single-center study.\n\nThe study is divided in two phases:\n\n* FIRST PHASE (retrospective): registration of all patients affected by pituitary disorders followed at the Unit of Endocrinology of Azienda Ospedaliero-Universitaria of Modena\n* SECOND PHASE (prospective): enrollment of all patients affected by pituitary disorders who attend the Unit of Endocrinology of the Azienda Ospedaliero-Universitaria of Modena.\n\nAn anonymized database will be created to collect the data of the patients. In particular, the data collected for each patient will include: personal data, data relating to pituitary pathology, symptoms at diagnosis, physical examination, radiological imaging, visual field data, data on surgical intervention, data on histological examination, biohumoral examinations, hormone tests, densitometric data, data on replacement therapies, medical therapies or other pharmacological therapies, data on comorbidities.",[65],"Pituitary","2025-03-12",{"date":68,"type":69},"2025-03-14","ACTUAL",{"date":71,"type":69},"2022-10-24",{"date":73,"type":60},"2031-10-24",{"name":5,"class":6},1]